metaraminol has been researched along with Stomach Neoplasms in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tatsuta, M | 1 |
| Iishi, H | 1 |
| Baba, M | 1 |
| Yano, H | 1 |
| Sakai, N | 1 |
| Uehara, H | 1 |
| Hirasawa, R | 1 |
| Nakaizumi, A | 1 |
1 other study available for metaraminol and Stomach Neoplasms
| Article | Year |
|---|---|
Alpha1-adrenoceptor stimulation enhances experimental gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adrenergic alpha-Agonists; Animals; Carcinogens; Clonidine; Gastric Mucosa; Incidence; Male; Metaram | 1998 |